High Content Screening Industry Has Transformed Rapidly in Past Few Couple of Decades
The global market for high content screening is currently witnessing the emergence of several notable trends from the product, application, and industry perspective. Growing concerns of pharmaceutical companies towards toxicity studies is shifting focus on secondary cell screening. Further, biotechnology and pharmaceutical companies are deploying high content screening solutions for effective risk assessment of critical illnesses to facilitate efficient drug discovery. Manufacturers in the high content screening market are offering advanced instruments to facilitate various lab services. These factors are...
View full press release